A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseStephen Salloway, Michael Grundman, Reisa A. Sperling et al.|Neurology|2009Cited by 739
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET imagesDonghuan Lu, Erin Franklin, Arthur W. Toga et al.|Scientific Reports|2018Cited by 380
Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task ForceBruno Vellas, María C. Carrillo, Cristina Sampaio et al.|Alzheimer s & Dementia|2013Cited by 145
Long-Term Treatment with Lithium Alleviates Memory Deficits and Reduces Amyloid-β Production in an Aged Alzheimer's Disease Transgenic Mouse ModelXin Zhang, Weidong Le, Xin Heng et al.|Journal of Alzheimer s Disease|2011Cited by 114
Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer’s disease neuropathology in APPSwe/PS1A246E transgenic miceXin Zhang, Weidong Le, Lixi Li et al.|Neurobiology of Aging|2012Cited by 62